• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Psychedelic Invest

Investing in Psychedelics

  • Home
  • News
    • Analysis
    • Interviews
    • Press
  • Index
  • Resources
    • Psychedelic Investors
    • Psychedelic Stocks
    • Psychedelic Law Firms
    • Events
    • Jobs
  • Invest

Analysis

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

January, 2021 Update: Psychedelic Index Adds 7 New Companies

January 2021 index update

Psychedelic Invest is excited to announce that we’ve added 7 new companies to the Psychedelic Invest Index – making us fully up to date on all recent listings. The Psychedelic Invest Index, the first-ever to track the entire public sector of the psychedelic market, now features: Tryp Therapeutics Inc (TRYP)BetterLife Pharma Inc. (BETR)Mindset Pharma Inc. (MSET)Entheon … [Read more...] about January, 2021 Update: Psychedelic Index Adds 7 New Companies

Novamind Goes Public and Carves Foothold In the Psychedelic Industry With a Unique Strategy in Mind

Novamind stock

“The standard of care in mental health is broken and has been for decades.” We were speaking with Yaron Conforti, the CEO and Director of Novamind about the catalyst that led to the creation of the company which is going public today, January 5th 2021. Yaron explained that mental health has been in crisis mode for decades. And that’s before COVID hit. Post-COVID, it’s … [Read more...] about Novamind Goes Public and Carves Foothold In the Psychedelic Industry With a Unique Strategy in Mind

Psychedelic Invest Index Gains 2.23% In December as Daily Volumes Surge

After gaining 54.66% in the month of November, the Psychedelic Invest Index had a much quieter month in December, finishing with a gain of only 2.23%. On Thursday, December 31, 2020, the index closed at a price of $86.69 and marked the end of what was a historic year for the entire psychedelic sector. Since launching in June of 2020, the Psychedelic Invest Index has … [Read more...] about Psychedelic Invest Index Gains 2.23% In December as Daily Volumes Surge

Tryp Therapeutics Goes Public; Here’s Everything You Need to Know

Tryp Therapeutics IPO

Tryp Therapeutics, a development-stage pharmaceutical company focused on psilocybin and other treatments, will begin trading on the Canadian Stock Exchange (CSE) today under the symbol “TRYP”. After initially attempting to sell 17.4 million units at $0.25 to investors, the company said Monday it would fully exercise its over-allotment option, increasing the total number of … [Read more...] about Tryp Therapeutics Goes Public; Here’s Everything You Need to Know

A New Fund Dedicated to Psychedelic Investments Has Launched in the UK

Neo Kuma Ventures

A firm touting itself as “Britain's first psychedelic healthcare fund” has launched with the intention to invest more than £10 million ($13.5 million) in psychedelic focused companies.  Neo Kuma Ventures will fund what it believes are "the most exciting, high quality and scientifically sound players in the industry." The fund has previously invested in atai Life … [Read more...] about A New Fund Dedicated to Psychedelic Investments Has Launched in the UK

Next Page »

Primary Sidebar

  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Recent Posts

  • Mydecine Innovations Group Files Application to list to the NASDAQ January 27, 2021
  • Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US January 26, 2021
  • Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression January 25, 2021
  • PharmaTher Signs License Agreement for Patented Ketamine Treatment January 22, 2021
  • January, 2021 Update: Psychedelic Index Adds 7 New Companies January 22, 2021
Psychedelics by TradingView

Interview Series

journey colab psychedelics
fluence psychedelic therapy
CaaMTech Davis Wuolle

Footer

Psychedelic Investor

Psychedelics are set to disrupt the multi billion dollar alcohol, tobacco, pharmaceutical, and health & wellness industries.

There is an enormous opportunity for those early investors who are able to look past the historical negative stigma associated with many psychedelics.

Psychedelic Invest is a resource for those looking to invest in the psychedelic industry.

Quick Links

  • About
  • Contact
  • Terms of Use
  • Psychedelic Stock Index
  • Careers

Subscribe

Copyright © 2021 · Psychedelic Invest